A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

Description

The goal of this study is to learn how \[14C\]MK-8527 moves through a healthy person's body over time. Researchers will study how \[14C\]MK-8527 is absorbed by the body, broken down by the body, and how it leaves the body.

Conditions

Healthy

Study Overview

Study Details

Study overview

The goal of this study is to learn how \[14C\]MK-8527 moves through a healthy person's body over time. Researchers will study how \[14C\]MK-8527 is absorbed by the body, broken down by the body, and how it leaves the body.

A Phase 1 Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]MK-8527 in Healthy Adult Participants

A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Madison

Fortea CRU Madison ( 0001), Madison, Wisconsin, United States, 53704

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is in good health
  • * Has a body mass index (BMI) of 18 to 32 kg/m\^2
  • * Has a history of cancer
  • * Has positive tests for hepatitis B surface antigen, hepatitis C antibodies or human immunodeficiency virus

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Merck Sharp & Dohme LLC,

Medical Director, STUDY_DIRECTOR, Merck Sharp & Dohme LLC

Study Record Dates

2025-05-21